These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12173980)
21. N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy. De Caro V; Scaturro AL; Sutera FM; Avellone G; Schiera G; Ferrantelli E; Carafa M; Rizzo V; Carletti F; Sardo P; Giannola LI Med Chem; 2014; 11(1):30-40. PubMed ID: 24813685 [TBL] [Abstract][Full Text] [Related]
22. Sodium Valproate Ameliorates Neuronal Apoptosis in a Kainic Acid Model of Epilepsy via Enhancing PKC-Dependent GABA Li Q; Li QQ; Jia JN; Cao S; Wang ZB; Wang X; Luo C; Zhou HH; Liu ZQ; Mao XY Neurochem Res; 2018 Dec; 43(12):2343-2352. PubMed ID: 30311181 [TBL] [Abstract][Full Text] [Related]
23. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells. Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line. Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577 [TBL] [Abstract][Full Text] [Related]
25. Teratogenicity of valproate conjugates with anticonvulsant activity in mice. Spiegelstein O; Chatterjie N; Alexander G; Finnell RH Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of action of valproate: a commentatory. Johannessen CU Neurochem Int; 2000; 37(2-3):103-10. PubMed ID: 10812195 [TBL] [Abstract][Full Text] [Related]
28. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Sgobio C; Ghiglieri V; Costa C; Bagetta V; Siliquini S; Barone I; Di Filippo M; Gardoni F; Gundelfinger ED; Di Luca M; Picconi B; Calabresi P Biol Psychiatry; 2010 Mar; 67(6):567-74. PubMed ID: 20074705 [TBL] [Abstract][Full Text] [Related]
29. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D; Lampen A; Nau H Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903 [TBL] [Abstract][Full Text] [Related]
30. Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy. Panagopoulos GR; Thomaides T; Tagaris G; Karageorgiou CL Acta Neurol Scand; 1997 Jul; 96(1):62-4. PubMed ID: 9262135 [TBL] [Abstract][Full Text] [Related]
31. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts? Janković SM; Janković SV Expert Opin Drug Discov; 2020 Nov; 15(11):1355-1364. PubMed ID: 32686964 [TBL] [Abstract][Full Text] [Related]
32. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity. Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397 [TBL] [Abstract][Full Text] [Related]
33. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton. Walmod PS; Skladchikova G; Kawa A; Berezin V; Bock E Cell Motil Cytoskeleton; 1999; 42(3):241-55. PubMed ID: 10098937 [TBL] [Abstract][Full Text] [Related]